RxSight Inc (RXST)
61.78
+2.14
(+3.60%)
USD |
NASDAQ |
May 03, 16:00
61.78
0.00 (0.00%)
After-Hours: 20:00
RxSight Revenue (TTM): 89.08M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 89.08M |
September 30, 2023 | 76.59M |
June 30, 2023 | 67.00M |
March 31, 2023 | 57.55M |
December 31, 2022 | 49.00M |
September 30, 2022 | 41.34M |
June 30, 2022 | 34.51M |
Date | Value |
---|---|
March 31, 2022 | 28.05M |
December 31, 2021 | 22.59M |
September 30, 2021 | 19.08M |
June 30, 2021 | 17.46M |
March 31, 2021 | 15.27M |
December 31, 2020 | 14.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.68M
Minimum
Dec 2020
89.08M
Maximum
Dec 2023
40.94M
Average
34.51M
Median
Jun 2022
Revenue (TTM) Benchmarks
Abbott Laboratories | 40.33B |
Alphatec Holdings Inc | 482.26M |
AtriCure Inc | 414.60M |
Intuitive Surgical Inc | 7.318B |
iRhythm Technologies Inc | 492.68M |